
==== Front
Adv TherAdv TherAdvances in Therapy0741-238X1865-8652Springer Healthcare Cheshire 3090019793010.1007/s12325-019-00930-9CorrectionCorrection to: Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review Park Yung Ki 1Yi Hyeong-Joong hjyi8499@hanyang.ac.kr 2Choi Kyu-Sun 2Lee Young-Jun 3Kim Dong-Won 4Kwon Sae Min 51 0000 0004 0470 4224grid.411947.eDepartment of Neurosurgery, Seoul St. Mary’s Hospital, The Catholic University of Korea, Seoul, Republic of Korea 2 0000 0004 4671 5423grid.411986.3Department of Neurosurgery, Hanyang University Medical Center, Seoul, Republic of Korea 3 0000 0004 4671 5423grid.411986.3Department of Radiology, Hanyang University Medical Center, Seoul, Republic of Korea 4 0000 0004 4671 5423grid.411986.3Department of Anesthesiology and Pain Medicine, Hanyang University Medical Center, Seoul, Republic of Korea 5 0000 0001 0842 2126grid.413967.eDepartment of Neurosurgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea 21 3 2019 21 3 2019 2019 36 6 1509 1509 © The Author(s) 2019Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.issue-copyright-statement© Springer Healthcare Ltd., part of Springer Nature 2019
==== Body
Correction to: Adv Ther (2018) 35:2224–2235 10.1007/s12325-018-0832-8
The article “Cerebrolysin for the Treatment of Aneurysmal Subarachnoid Hemorrhage in Adults: A Retrospective Chart Review”, written by Yung Ki Park, Hyeong-Joong Yi, Kyu-Sun Choi, Young-Jun Lee, Dong-Won Kim, Sae Min Kwon was originally published electronically on the publisher’s internet portal (currently SpringerLink) on November 9, 2018 without open access.

The copyright of the article changed to © The Author(s) 2018 and the article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any non-commercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and Indicate if changes were made.

The funding information has been updated as “No funding or sponsorship was received for this study. EVER Pharmaceuticals funded the article processing charges and open access fee”.

The original article has been corrected.

